报价延迟最少15分钟:2025/08/26 16:46 EDT
盘后时段
|
||||
|
248.58 
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
248.58
|
|
|
| 价值评估 |
|
盈利(现时/预测)
6.53/10.17
|
|
企业价值
26.52B
|
| 资产负债 |
|
每股账面净值
70.64
|
| 现金流量 |
|
现金流量率
0.05
|
| 损益表 |
|
收益
5.46B
|
|
每股收益
53.08
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
报价延迟最少15分钟：2025/08/26 16:46 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business. |
